These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 21503575)
1. Human complement factor H is a novel diagnostic marker for lung adenocarcinoma. Cui T; Chen Y; Knösel T; Yang L; Zöller K; Galler K; Berndt A; Mihlan M; Zipfel PF; Petersen I Int J Oncol; 2011 Jul; 39(1):161-8. PubMed ID: 21503575 [TBL] [Abstract][Full Text] [Related]
2. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux. Cohen AJ; Bunn PA; Franklin W; Magill-Solc C; Hartmann C; Helfrich B; Gilman L; Folkvord J; Helm K; Miller YE Cancer Res; 1996 Feb; 56(4):831-9. PubMed ID: 8631021 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703 [TBL] [Abstract][Full Text] [Related]
4. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival. Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of eukaryotic initiation factor 4E (eIF4E) and its clinical significance in lung adenocarcinoma. Wang R; Geng J; Wang JH; Chu XY; Geng HC; Chen LB Lung Cancer; 2009 Nov; 66(2):237-44. PubMed ID: 19261348 [TBL] [Abstract][Full Text] [Related]
6. A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma. Tsai MF; Wang CC; Chang GC; Chen CY; Chen HY; Cheng CL; Yang YP; Wu CY; Shih FY; Liu CC; Lin HP; Jou YS; Lin SC; Lin CW; Chen WJ; Chan WK; Chen JJ; Yang PC J Natl Cancer Inst; 2006 Jun; 98(12):825-38. PubMed ID: 16788156 [TBL] [Abstract][Full Text] [Related]
7. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma. Sugita M; Geraci M; Gao B; Powell RL; Hirsch FR; Johnson G; Lapadat R; Gabrielson E; Bremnes R; Bunn PA; Franklin WA Cancer Res; 2002 Jul; 62(14):3971-9. PubMed ID: 12124329 [TBL] [Abstract][Full Text] [Related]
8. IGFBP7 is a p53 target gene inactivated in human lung cancer by DNA hypermethylation. Chen Y; Cui T; Knösel T; Yang L; Zöller K; Petersen I Lung Cancer; 2011 Jul; 73(1):38-44. PubMed ID: 21095038 [TBL] [Abstract][Full Text] [Related]
9. Caveolins as tumour markers in lung cancer detected by combined use of cDNA and tissue microarrays. Wikman H; Seppänen JK; Sarhadi VK; Kettunen E; Salmenkivi K; Kuosma E; Vainio-Siukola K; Nagy B; Karjalainen A; Sioris T; Salo J; Hollmén J; Knuutila S; Anttila S J Pathol; 2004 May; 203(1):584-93. PubMed ID: 15095482 [TBL] [Abstract][Full Text] [Related]
10. Expression of nucleolar protein p120 in human lung cancer: difference in histological types as a marker for proliferation. Uchiyama B; Saijo Y; Kumano N; Abe T; Fujimura S; Ohkuda K; Handa M; Satoh K; Nukiwa T Clin Cancer Res; 1997 Oct; 3(10):1873-7. PubMed ID: 9815576 [TBL] [Abstract][Full Text] [Related]
11. Prognostic implications of calbindin-D28k expression in lung cancer: analysis of 452 cases. Castro CY; Stephenson M; Gondo MM; Medeiros LJ; Cagle PT Mod Pathol; 2000 Jul; 13(7):808-13. PubMed ID: 10912942 [TBL] [Abstract][Full Text] [Related]
12. The correlation between aberrant connexin 43 mRNA expression induced by promoter methylation and nodal micrometastasis in non-small cell lung cancer. Chen JT; Cheng YW; Chou MC; Sen-Lin T; Lai WW; Ho WL; Lee H Clin Cancer Res; 2003 Sep; 9(11):4200-4. PubMed ID: 14519646 [TBL] [Abstract][Full Text] [Related]
13. Clinical implication and prognostic significance of the tumor suppressor TSLC1 gene detected in adenocarcinoma of the lung. Uchino K; Ito A; Wakayama T; Koma Y; Okada T; Ohbayashi C; Iseki S; Kitamura Y; Tsubota N; Okita Y; Okada M Cancer; 2003 Sep; 98(5):1002-7. PubMed ID: 12942568 [TBL] [Abstract][Full Text] [Related]
14. Expression of CEA and trophoblastic cell markers by lung carcinoma in association with histological characteristics and serum marker levels. Slodkowska J; Szturmowicz M; Rudzinski P; Giedronowicz D; Sakowicz A; Androsiuk W; Zakrzewska-Rowinska E Eur J Cancer Prev; 1998 Feb; 7(1):51-60. PubMed ID: 9511851 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results. Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205 [TBL] [Abstract][Full Text] [Related]
16. Reduced transcription of the RB2/p130 gene in human lung cancer. Xue Jun H; Gemma A; Hosoya Y; Matsuda K; Nara M; Hosomi Y; Okano T; Kurimoto F; Seike M; Takenaka K; Yoshimura A; Toyota M; Kudoh S Mol Carcinog; 2003 Nov; 38(3):124-9. PubMed ID: 14587097 [TBL] [Abstract][Full Text] [Related]
17. Up-regulation of proline-rich tyrosine kinase 2 in non-small cell lung cancer. Zhang S; Qiu X; Gu Y; Wang E Lung Cancer; 2008 Dec; 62(3):295-301. PubMed ID: 18571765 [TBL] [Abstract][Full Text] [Related]